agilon health (AGL) director Williams received 2,133 shares
Insider transactions reported
Ronald A Williams (director at agilon health inc., AGL) reported that they received 2,133 shares on Jun 2, 2026. After these transactions the filing shows 149,141 shares held directly.
- Reporting person
- Williams Ronald A
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Grant or award (A) | Common Stock1, 2, 3 | +2,133 | - | - | 149,141 direct |
Holdings before and after
- Common Stock: 147,008 to 149,141 direct
Footnotes from the filing
- 1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director
- 2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
- 3. Includes restricted stock units.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Williams report in this AGL Form 4?
Ronald A Williams (director at agilon health inc., AGL) reported that they received 2,133 shares on Jun 2, 2026. After these transactions the filing shows 149,141 shares held directly.
How many AGL shares does Williams hold after this filing?
The filing shows 149,141 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for AGL
Across the 8 sessions after earlier AGL headlines, the stock closed higher 4 times and lower 4 times, with a median move of 7.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AGL | SPY |
|---|---|---|---|
| May 26, 2026 | agilon health upgraded by Barclays with a new price target | -1.3% | +0.7% |
| May 7, 2026 | agilon health upgraded by Jefferies with a new price targetand 1 other headline that session | +117.8% | -0.3% |
| May 4, 2026 | Agilon Health downgraded by Analyst with a new price target | -8.9% | -0.4% |
| Apr 28, 2026 | agilon health Appoints Tim O'Rourke as Chief Executive Officer | +10.2% | -0.5% |
| Apr 7, 2026 | agilon health Sets Date to Report First Quarter 2026 Financial Results | +18.8% | +0.0% |
| Feb 18, 2026 | agilon health to Participate in Upcoming Conferences | +6.5% | +0.5% |
Earlier insider filings at AGL
- Jun 5, 2026Director Mcloughlin Karen was granted 2,133 shares, increasing direct ownership by 35% to 8,207 units (SEC Form 4)
- Jun 5, 2026Director Mckenzie Diana was granted 2,133 shares, increasing direct ownership by 39% to 7,633 units (SEC Form 4)
- Jun 5, 2026Director Mansukani Sharad was granted 2,133 shares, increasing direct ownership by 4% to 56,242 units (SEC Form 4)
- Jun 5, 2026Director Battaglia Silvana was granted 2,133 shares, increasing direct ownership by 37% to 7,926 units (SEC Form 4)
- May 28, 2026Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 8 shares, decreasing direct ownership by 0.06% to 14,169 units (SEC Form 4) (for withholding tax)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Listed since
- 2021
Follow AGL and get a push notification the moment its next story breaks.